Question 1

Does Woodline Partners own SLN stock?

Accepted Answer

No. Woodline Partners exited its SLN (Silence Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 62,459 shares worth $324,162.

Question 2

How many shares of SLN does Woodline Partners own?

Accepted Answer

None since Q4 2025, when Woodline Partners exited the position. Its Q3 2025 13F listed 62,459 shares worth $324,162.

Question 3

What is Woodline Partners' SLN position worth?

Accepted Answer

Woodline Partners' SLN position was worth $324,162 in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Woodline Partners buying or selling SLN?

Accepted Answer

In Q4 2025, Woodline Partners exited its entire SLN position.

Question 5

When did Woodline Partners first buy SLN?

Accepted Answer

Woodline Partners first reported SLN in its Q3 2022 13F and listed it in 13 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$6.08	0
2025-Q3	Unchanged	62,459	0.0%	$324,162	0.0%	$5.19	0
2025-Q2	Decreased	62,459	-53.6%	$362,262	0.0%	$5.80	0
2025-Q1	Decreased	134,492	-73.0%	$379,267	0.0%	$2.82	0
2024-Q4	Increased	498,732	+22.6%	$3.4M	0.0%	$6.88	32
2024-Q3	Increased	406,903	+347.8%	$7.4M	0.1%	$18.25	44